Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1J9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,862
Award facts
- Contract value 100% obligated
- $57,862.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $57,862.08 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, for the supply of Zepbound 12.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 7, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of Amerisourcebergen Drug Corp's corporate office. This delivery order is executed under Amerisourcebergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a wide range of pharmaceutical products to military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contracting history demonstrates its capability to compete successfully for both routine pharmaceutical deliveries and complex medical supply requirements. Zepbound, a weight-management medication, represents one of numerous specialty pharmaceutical products the company delivers under its contract portfolio, which encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, and other specialized healthcare commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA1J9?
SPE2DR26FA1J9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FA1J9 worth?
The government has obligated $57,862 on SPE2DR26FA1J9.
Is contract SPE2DR26FA1J9 an order under another contract?
Yes. SPE2DR26FA1J9 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1J9 competed?
The extent of competition for SPE2DR26FA1J9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award